[<i>Shengmai San</i> improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway]. [PDF]
Liang Z +6 more
europepmc +1 more source
[<i>Poria cocos</i> polysaccharide alleviates cyclophosphamide-induced intestinal barrier dysfunction and inflammation in mice by modulating gut flora]. [PDF]
Zhang Y +10 more
europepmc +1 more source
[Research progress on the multidimensional regulation of gut microbiota on metabolism, immunity, and inflammatory response in metabolic associated fatty liver disease]. [PDF]
Wu ST, Lu XL.
europepmc +1 more source
[[abstract]]本发明提供了一种纳米级乳液免疫载剂及其制备方法,其由下列组成成分所组成:一含有H2O分子的一连续水相;含有油脂的一油相物质;以及用于稳定连续水相和油相界面的一乳化统,且该乳化统为乳化剂混合物,该免疫载剂的特征在于,该乳化统不含离子型乳化剂,且该乳液的粒径大小介于20纳米至200纳米之间。通过该纳米级乳液免疫载剂,其可有效避免离子型乳化剂对人体细胞带来的毒性及可能的危害 ...
黄明熙;黄崇雄;黄琼仪
core
[Research progress on poor response, resistance mechanisms, and influencing factors of immunotherapy for hepatocellular carcinoma]. [PDF]
Huang M +5 more
europepmc +1 more source
[Pathophysiological mechanisms of coagulation dysfunction associated with liver disease]. [PDF]
Wang H, Chen X, Lu YY.
europepmc +1 more source
[Type Ⅱ first branchial cleft anomaly with parotid fistula: a case report and literature review]. [PDF]
Wang T, Zhou Z, Shi G.
europepmc +1 more source
[Research advances on the targeted programmed cell death regulatory network for treatment of refractory diabetic wounds]. [PDF]
Zhang ZH, He WF.
europepmc +1 more source
[Using activity-based protein profiling method to explore the antitumor targets of spiramycin derivatives]. [PDF]
Yang RY, Feng TZ, Pei SJ, Qi H, Piao HL.
europepmc +1 more source
[Design and synthesis of molecularly imprinted polymers and their applications in medical diagnosis and biocatalysis]. [PDF]
Song Q, Li X, Lyu Y.
europepmc +1 more source

